Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-Analysis From 2000 to 2020 Publisher Pubmed



Curran K55, 189 ; Peto T55, 189 ; Jonas JB1, 58, 59 ; Friedman D2 ; Kim JE3 ; Leasher J4, 57 ; Tapply I5 ; Fernandes AG6, 7, 62 ; Cicinelli MV8, 9 ; Arrigo A10 ; Leveziel N11, 12 ; Resnikoff S13, 14 ; Taylor HR15 ; Sedighi T16 Show All Authors
Authors
  1. Curran K55, 189
  2. Peto T55, 189
  3. Jonas JB1, 58, 59
  4. Friedman D2
  5. Kim JE3
  6. Leasher J4, 57
  7. Tapply I5
  8. Fernandes AG6, 7, 62
  9. Cicinelli MV8, 9
  10. Arrigo A10
  11. Leveziel N11, 12
  12. Resnikoff S13, 14
  13. Taylor HR15
  14. Sedighi T16
  15. Flaxman S17
  16. Bikbov MM18
  17. Braithwaite T19, 20, 93, 94
  18. Bron A21
  19. Cheng CY22, 23
  20. Del Monte MA24, 25
  21. Ehrlich JR26, 27
  22. Furtado JM28, 116
  23. Gazzard G29
  24. Hartnett ME31
  25. Kahloun R32
  26. Kempen JH33, 34, 35, 36
  27. Khairallah M37
  28. Khanna RC38, 39, 40, 41
  29. Lansingh VC42, 43, 44
  30. Naidoo KS40, 45
  31. Nangia V46
  32. Nowak M47
  33. Pesudovs K48
  34. Ramulu P50
  35. Topouzis F51, 179
  36. Tsilimbaris M52
  37. Wang YX53
  38. Wang N54
  39. Bourne RRA16, 56
  40. Friedman DS60
  41. Kim JE3
  42. Ahinkorah BO63
  43. Ahmadieh H64, 65
  44. Ahmed A66, 67
  45. Alfaar AS68, 69
  46. Almidani L70, 71
  47. Amu H72
  48. Androudi S73
  49. Arabloo J74
  50. Aravkin AY75, 76, 77
  51. Asemu MT78
  52. Azzam AY79, 80
  53. Baghcheghi N81
  54. Bailey F82
  55. Baran MF83
  56. Bardhan M84
  57. Barnighausen TW85, 86
  58. Barrow A87, 88
  59. Bhardwaj P90, 91
  60. Bikbov M92
  61. Briant PS76
  62. Burkart K76, 77
  63. Camera LA96, 97
  64. Coberly K76
  65. Dadras O98, 99
  66. Dai X76, 77
  67. Dehghan A100
  68. Demessa BH101
  69. Diress M102
  70. Do TC103
  71. Do THP104
  72. Dokova KG105
  73. Duncan BB106
  74. Ekholuenetale M107, 108
  75. Elhadi M109
  76. Emamian MH110
  77. Emamverdi M111
  78. Farrokhpour H112, 113
  79. Fatehizadeh A114
  80. Desideri LF115
  81. Gebrehiwot M117
  82. Ghassemi F118
  83. Gudeta MD119
  84. Gupta S120
  85. Gupta VB121
  86. Gupta VK122
  87. Hammond BR123
  88. Harorani M124
  89. Hasani H125
  90. Heidari G126
  91. Hosseinzadeh M127, 128
  92. Huang JJ129
  93. Islam SMS130, 131
  94. Javadi N132, 133
  95. Jimenezcorona A134, 135
  96. Jokar M136, 137
  97. Joshua CE138
  98. Kadashetti V139
  99. Kandel H140, 141
  100. Kasraei H142, 143
  101. Kaur RJ144
  102. Khanal S145
  103. Khorrami Z146
  104. Koohestani HR147
  105. Krishan K148
  106. Lim SS76, 77
  107. El Razek MMA149
  108. Mansouri V151
  109. Maugeri A152
  110. Mestrovic T76, 153
  111. Misganaw A77, 154
  112. Mokdad AH76, 77
  113. Momenimoghaddam H155
  114. Momtazmanesh S112, 158
  115. Murray CJL76, 77
  116. Negash H159
  117. Osuagwu UL160, 161
  118. Pardhan S16
  119. Patel J162, 163
  120. Pawar S164
  121. Petcu IR165
  122. Pham HT166
  123. Pourazizi M167
  124. Qattea I168
  125. Rahman M169
  126. Saeed U170, 171
  127. Sahebkar A172, 173
  128. Salehi MA174
  129. Shayan M175, 176
  130. Shittu A177
  131. Steinmetz JD76
  132. Tan Y178
  133. Tsatsakis A180
  134. Umair M181, 182
  135. Vos T76, 77
  136. Xiao H183, 184
  137. You Y140, 185
  138. Zastrozhin MS186, 187, 188
  139. Zheng P76, 77

Source: Eye (Basingstoke) Published:2024


Abstract

Objectives: To estimate global and regional trends from 2000 to 2020 of the number of persons visually impaired by diabetic retinopathy and their proportion of the total number of vision-impaired individuals. Methods: Data from population-based studies on eye diseases between 1980 to 2018 were compiled. Meta-regression models were performed to estimate the prevalence of blindness (presenting visual acuity <3/60) and moderate or severe vision impairment (MSVI; <6/18 to ≥3/60) attributed to DR. The estimates, with 95% uncertainty intervals [UIs], were stratified by age, sex, year, and region. Results: In 2020, 1.07 million (95% UI: 0.76, 1.51) people were blind due to DR, with nearly 3.28 million (95% UI: 2.41, 4.34) experiencing MSVI. The GBD super-regions with the highest percentage of all DR-related blindness and MSVI were Latin America and the Caribbean (6.95% [95% UI: 5.08, 9.51]) and North Africa and the Middle East (2.12% [95% UI: 1.55, 2.79]), respectively. Between 2000 and 2020, changes in DR-related blindness and MSVI were greater among females than males, predominantly in the super-regions of South Asia (blindness) and Southeast Asia, East Asia, and Oceania (MSVI). Conclusions: Given the rapid global rise in diabetes and increased life expectancy, DR is anticipated to persist as a significant public health challenge. The findings emphasise the need for gender-specific interventions and region-specific DR healthcare policies to mitigate disparities and prevent avoidable blindness. This study contributes to the expanding body of literature on the burden of DR, highlighting the need for increased global attention and investment in this research area. © The Author(s) 2024.
Other Related Docs
11. A Risk Score Development for Diabetic Retinopathy Screening in Isfahan-Iran, Journal of Research in Medical Sciences (2009)